Organizational/Institutional Members shall designate a representative member and an alternate member. Each member organization shall have full membership rights, including the right to attend NLCRT meetings, to participate in discussions, to vote, to be a candidate for elective office, and to accept appointments to committees and strategic priority Task Groups. Members with governmental affiliation (designated as non-advocacy members) will abstain from voting on policy issues.

Invited Individuals include those with outstanding expertise in reducing lung cancer morbidity and mortality, promoting tobacco treatment, and a commitment to quality of life for individuals with lung cancer, their families, and survivors. Individual members shall have all of the participatory benefits of organizational/institutional members. Individuals must be invited to apply.

Corporate Associates shall have the right to attend NLCRT meetings and participate in discussions with NLCRT leadership. These members will neither have voting rights nor the right to serve on a Task Group or as an elected officer of the NLCRT.  This policy is in place to avoid the appearance of a conflict of interest. Industry representatives may participate in subgroup and priority initiative meetings, but they cannot be formal members.

They must demonstrate a commitment to:

• Creating products that aid in risk reduction, early detection, assurance of optimal diagnosis and therapy, and elimination of lung cancer-related stigma. The efficacy of these products must be supported by scientific research.
• Demonstrate a commitment to patient and provider lung cancer education and high-quality screening.